A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20100147)

Published in Acta Oncol on January 01, 2010

Authors

Chiara Catania1, G Pelosi, N Fazio, R Biffi, G Spitaleri, C Noberasco, M G Zampino, A Maggioni, G Trifirò, F Toffalorio, P Della Vigna, F De Braud, T De Pas

Author Affiliations

1: Division of New Drugs Development and Clinical Pharmacology, European Institute of Oncology Ripamonti 435 Milan, Italy. chiara.catania@ieo.it

Articles by these authors

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol (2005) 5.82

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation (1999) 2.79

Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol (2004) 2.31

Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes. Surg Endosc (2010) 2.18

Synthesis, structural characterization and biological activity of p-fluorobenzaldehyde thiosemicarbazones and of a nickel complex. J Inorg Biochem (2000) 2.13

Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ (2014) 2.06

The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J (2000) 1.90

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Ann Oncol (2000) 1.79

A randomized comparison of Burch colposuspension and abdominal paravaginal defect repair for female stress urinary incontinence. Am J Obstet Gynecol (1996) 1.54

Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer. Jpn J Clin Oncol (1998) 1.48

Jaw avascular bone necrosis associated with long-term use of biphosphonates. Ann Oncol (2005) 1.45

[Brain death and prolonged fetal survival]. Minerva Anestesiol (1992) 1.42

Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy. Ann Oncol (2006) 1.38

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS (1999) 1.36

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur J Nucl Med (1999) 1.32

Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 study. Am J Cardiol (1998) 1.31

Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann Oncol (2009) 1.28

230 patient years of experience with home long-term parenteral nutrition in childhood: natural history and life of central venous catheters. J Pediatr Surg (1994) 1.27

Breast metastases from cutaneous malignant melanoma. Breast (2004) 1.21

Molecular and genomic analysis of genes encoding surface-anchored proteins from Clostridium difficile. Infect Immun (2001) 1.20

High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible? Ann Oncol (1998) 1.19

Expression of progesterone receptors in solid-cystic tumour of the pancreas: a clinicopathological and immunohistochemical study of ten cases. Virchows Arch A Pathol Anat Histopathol (1993) 1.18

Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma. J Clin Oncol (1994) 1.16

Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor. Oncogene (2009) 1.16

Management of recurrent cervical cancer: a review of the literature. Surg Oncol (2012) 1.14

Peripheral giant cell granuloma: evidence for osteoclastic differentiation. Oral Surg Oral Med Oral Pathol (1990) 1.14

A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer (2001) 1.14

Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis. Int J Cancer (1997) 1.12

Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation (1995) 1.10

The case of GISSI in changing the attitudes and practice of Italian cardiologists. Stat Med (1990) 1.09

Preoperative chemotherapy is essential for conservative surgery of Askin tumors. J Thorac Cardiovasc Surg (2003) 1.09

Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma. Eur J Cancer (2004) 1.08

Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects. Q J Nucl Med (2002) 1.08

Breast and ovarian metastatic localization of signet-ring cell gastric carcinoma. Ann Oncol (2003) 1.08

In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation (1990) 1.06

Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost (2011) 1.05

Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. Cancer Res (1995) 1.05

Crystal structure of yeast Cu,Zn superoxide dismutase. Crystallographic refinement at 2.5 A resolution. J Mol Biol (1992) 1.05

Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treat Rev (2010) 1.05

Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer (2007) 1.04

Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate. Ann Oncol (2007) 1.04

Classification of lymph node metastases from carcinoma of the stomach: comparison of the old (1987) and new (1997) TNM systems. World J Surg (1999) 1.04

Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones. Bioorg Med Chem (2000) 1.03

Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltration. Int J Cancer Suppl (1994) 1.00

Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer. Eur J Cancer (2008) 1.00

A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer (1991) 0.99

Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr (2003) 0.99

Chemotherapy in pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci (2010) 0.99

Metal stent placement in acute malignant colorectal obstruction. Dig Liver Dis (2006) 0.99

Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med (2002) 0.99

Crystallization and preliminary X-ray diffraction studies on a recombinant isopenicillin N synthase from Cephalosporium acremonium. J Mol Biol (1994) 0.98

A survey on Prader-Willi syndrome in the Italian population: prevalence of historical and clinical signs. J Pediatr Endocrinol Metab (2009) 0.97

Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. Ann Oncol (2009) 0.97

Lymphatic mapping to tailor selective lymphadenectomy in cN0 tongue carcinoma: beyond the sentinel node concept. Eur J Nucl Med Mol Imaging (2006) 0.97

Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005. Eur J Neurol (2007) 0.97

Sentinel node biopsy in early vulvar cancer. Br J Cancer (2000) 0.96

Molecularly targeted endocrine therapies for breast cancer. Cancer Treat Rev (2010) 0.96

Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer (2013) 0.96

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients. Br J Cancer (2006) 0.96

Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions. Eur J Nucl Med Mol Imaging (2003) 0.96

Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis. J Thorac Cardiovasc Surg (2003) 0.96

Breast cancer vaccines: a clinical reality or fairy tale? Ann Oncol (2005) 0.96

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study. Br J Cancer (2011) 0.96

ICRF 159 plus radiation versus radiation therapy alone in cervical carcinoma. A double-blind study. Oncology (1983) 0.94

Waist circumference as a predictor of cardiovascular and metabolic risk factors in obese girls. Eur J Clin Nutr (2003) 0.93

Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Fail (2001) 0.93

Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours. Ann Oncol (2009) 0.93

Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. J Clin Oncol (1998) 0.93

Synthesis, characterisation and biological activity of three copper (II) complexes with a modified nitrogenous base: 5-formyluracil thiosemicarbazone. J Inorg Biochem (1998) 0.93

Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer. Ann Oncol (2001) 0.93

Prediction of response to primary chemotherapy for operable breast cancer. Eur J Cancer (1999) 0.92

Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p. J Pathol (1998) 0.91

In vivo radiofrequency-based ultrasonic tissue characterization of the atherosclerotic plaque. Stroke (1993) 0.91

bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer. Clin Cancer Res (1998) 0.91

Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patients. Biopharm Drug Dispos (2001) 0.90

Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol (1994) 0.89

Neuroendocrine tumour arising inside a retro-rectal tailgut cyst: report of two cases and a review of the literature. Ecancermedicalscience (2011) 0.89

Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR-positive advanced colorectal cancer treated with gefitinib? Cancer Chemother Pharmacol (2008) 0.88

A rare association of synchronous intraductal carcinoma of the breast and invasive carcinoma of ectopic breast tissue of the vulva: case report and literature review. Int J Gynecol Cancer (2006) 0.88

TIPS allowing for an endoscopic mucosal resection of early gastric cancer in a cirrhotic patient with severe hypertensive gastropathy: report of a case. Surg Today (1999) 0.88

Prognostic significance of 67-kDa laminin receptor expression in advanced gastric cancer. Oncology (1998) 0.88

Sebaceous lymphadenoma of salivary gland: a case report and a review of the literature. Acta Otorhinolaryngol Ital (2007) 0.88

Early oral versus "traditional" postoperative feeding in gynecologic oncology patients undergoing intestinal resection: a randomized controlled trial. Ann Surg Oncol (2009) 0.88